Vision tests are an important part of life, but they aren’t always the most convenient things to work into your schedule. It’s an issue Eyebot thinks it has solved with its kiosk, which shrinks the ...

Putting on a show as grand as the Times Square Ball Drop in New York City is quite the challenge. To ensure things run smoothly ahead of the major celebrations, organizers of the New Year's Eve ...

Before the Times Square ball drops to usher in 2026, organizers of the global spectacle test launched colorful confetti into the Crossroads of the World. The multicolored confetti was launched at 11 a ...

CLEVELAND, Ohio -- Monty Python’s “Spamalot” is embarking on a quest to hit more than two dozen cities over the next nine months, and Cleveland is the first stop. Based on the cult comedy classic ...

Get the Ugg Classic Short II Boots on Amazon! What makes these boots add-to-cart worthy is how they seamlessly blend celebrity cool with everyday comfort. The mid-calf height is flattering and easy to ...

Abbott is getting into cancer testing with its $21 billion acquisition Exact Sciences, the maker of the game-changing colorectal cancer test Cologuard. Abbott markets well-known diagnostics for ...

Abbott made a takeover offer for Exact Sciences. The two companies want to team up to combat cancer. Under the terms of the deal, Exact Sciences' stockholders would receive $105 per share in cash. The ...

The pending $23 billion sale of Madison-based Exact Sciences to health care giant Abbott centers on Exact Sciences' flagship product: colorectal cancer test Cologuard. Exact Sciences markets Cologuard ...

Forbes contributors publish independent expert analyses and insights. Bruce Japsen writes about healthcare business and policy. Abbott Laboratories $21 billion deal to acquire cancer test maker Exact ...

Shares of Exact Sciences (EXAS) continued to rise in the premarket on Thursday, adding ~18% after the cancer test maker agreed to be acquired by Abbott Laboratories (ABT) in an all-cash deal worth ...

The acquisition will allow the diagnostics giant to enter the rapidly growing market for cancer tests Exact Sciences sells Cologuard, the at-home test for colorectal cancer that allows some patients ...